Jane Street
ELDN icon

Jane Street’s Eledon Pharmaceuticals ELDN Stock Holding History

Jane Street’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.5K Sell
14,600
-34,300
-70% -$125K ﹤0.01% 10873
2026
Q1 		$151K Buy
+48,900
New +$115K ﹤0.01% 10387

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Jane Street's ELDN Position: Q2 2026 in Review

Jane Street opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 22,379 shares worth $88.2K. The stake represents ﹤0.01% of the portfolio and ranks #10664 among its holdings. This is a return to the name: Jane Street previously reported a position in ELDN as recently as Q4 2025.

Jane Street first reported a position in ELDN in Q2 2019 and has held it in 8 quarters since. The position peaked at $761K in Q1 2025. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Jane Street held 22,379 shares of Eledon Pharmaceuticals worth $88.2K as of Q2 2026.
  • Eledon Pharmaceuticals was a new Jane Street position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10664 holding.
  • Jane Street first reported a position in Eledon Pharmaceuticals in Q2 2019 and has held it in 8 quarters since.
  • Jane Street's Eledon Pharmaceuticals position peaked at $761K in Q1 2025.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.